Scott B.  Ullem net worth and biography

Scott Ullem Biography and Net Worth

Scott B. Ullem has been corporate vice president, chief financial officer since January 2014. In addition, Ullem has executive responsibility for the company’s information technology, information security, risk management, indirect sourcing, and corporate services teams.  Prior to joining Edwards, he served as chief financial officer of Bemis Company Inc., a Fortune 500 publicly traded global supplier of packaging and pressure sensitive materials used in leading food, consumer, and healthcare products, from May 2010 to December 2013.  Ullem also had leadership responsibility for one of Bemis' three business segments and the company's information technology function. Prior to Bemis, Ullem spent 17 years in investment banking, serving as managing director at Goldman Sachs and later at Bank of America. He has served on the board and compensation committee of Berry Global, Inc., since 2016, and is a Henry Crown Fellow at the Aspen Institute. He is a passionate supporter of healthcare initiatives aimed at improving hospital quality and safety. In 2014, he joined the board of the Edwards Lifesciences Foundation. Ullem received his bachelor's degree in political science from DePauw University and his master's degree in business administration from Harvard Business School.

What is Scott B. Ullem's net worth?

The estimated net worth of Scott B. Ullem is at least $1.64 million as of April 1st, 2024. Mr. Ullem owns 19,074 shares of Edwards Lifesciences stock worth more than $1,639,220 as of April 21st. This net worth estimate does not reflect any other investments that Mr. Ullem may own. Additionally, Mr. Ullem receives a salary of $1,350,000.00 as CFO at Edwards Lifesciences. Learn More about Scott B. Ullem's net worth.

How old is Scott B. Ullem?

Mr. Ullem is currently 57 years old. There are 6 older executives and no younger executives at Edwards Lifesciences. The oldest executive at Edwards Lifesciences is Mr. Arnold A. Pinkston, Corporate VP & General Counsel, who is 65 years old. Learn More on Scott B. Ullem's age.

What is Scott B. Ullem's salary?

As the CFO of Edwards Lifesciences Co., Mr. Ullem earns $1,350,000.00 per year. There are 2 executives that earn more than Mr. Ullem. The highest earning executive at Edwards Lifesciences is Mr. Bernard J. Zovighian, CEO & Director, who commands a salary of $2,270,000.00 per year. Learn More on Scott B. Ullem's salary.

How do I contact Scott B. Ullem?

The corporate mailing address for Mr. Ullem and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Scott B. Ullem's contact information.

Has Scott B. Ullem been buying or selling shares of Edwards Lifesciences?

During the past quarter, Scott B. Ullem has sold $688,426.95 in shares of Edwards Lifesciences stock. Most recently, Scott B. Ullem sold 7,255 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $94.89, for a transaction totalling $688,426.95. Following the completion of the sale, the chief financial officer now directly owns 19,074 shares of the company's stock, valued at $1,809,931.86. Learn More on Scott B. Ullem's trading history.

Who are Edwards Lifesciences' active insiders?

Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.

Are insiders buying or selling shares of Edwards Lifesciences?

In the last year, insiders at the medical research company sold shares 60 times. They sold a total of 768,312 shares worth more than $62,771,727.15. The most recent insider tranaction occured on April, 8th when VP Jean-Luc M Lemercier sold 14,400 shares worth more than $1,329,408.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.

Information on this page was last updated on 4/8/2024.

Scott B. Ullem Insider Trading History at Edwards Lifesciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2024Sell7,255$94.89$688,426.9519,074View SEC Filing Icon  
2/29/2024Sell7,255$85.59$620,955.4519,074View SEC Filing Icon  
2/1/2024Sell7,255$78.29$567,993.9519,248View SEC Filing Icon  
12/29/2023Sell14,510$76.55$1,110,740.5019,248View SEC Filing Icon  
10/31/2023Sell7,255$62.66$454,598.3019,248View SEC Filing Icon  
9/29/2023Sell7,255$69.54$504,512.7019,248View SEC Filing Icon  
8/31/2023Sell7,255$77.79$564,366.4519,248View SEC Filing Icon  
7/31/2023Sell7,255$84.35$611,959.2519,248View SEC Filing Icon  
6/30/2023Sell7,255$93.27$676,673.8519,248View SEC Filing Icon  
5/10/2023Sell80,700$88.54$7,145,178.0018,294View SEC Filing Icon  
10/26/2020Sell33,150$78.81$2,612,551.5060,264View SEC Filing Icon  
10/12/2020Sell33,150$83.81$2,778,301.5060,264View SEC Filing Icon  
9/28/2020Sell33,150$78.11$2,589,346.5060,264View SEC Filing Icon  
9/14/2020Sell26,700$82.21$2,195,007.0053,814View SEC Filing Icon  
8/6/2020Sell26,700$77.31$2,064,177.0053,814View SEC Filing Icon  
7/6/2020Sell26,700$69.98$1,868,466.0053,814View SEC Filing Icon  
6/22/2020Sell26,700$69.51$1,855,917.0027,114View SEC Filing Icon  
1/7/2020Sell7,500$234.25$1,756,875.0017,438View SEC Filing Icon  
12/10/2019Sell7,500$233.88$1,754,100.0017,438View SEC Filing Icon  
11/12/2019Sell7,500$234.28$1,757,100.0017,438View SEC Filing Icon  
10/29/2019Sell7,500$235.30$1,764,750.009,938View SEC Filing Icon  
9/9/2019Sell7,500$225.74$1,693,050.0021,064View SEC Filing Icon  
8/26/2019Sell7,500$213.44$1,600,800.0021,064View SEC Filing Icon  
9/5/2018Sell25,036$140.04$3,506,041.4441,019View SEC Filing Icon  
7/3/2018Sell25,000$145.67$3,641,750.0041,265View SEC Filing Icon  
6/6/2018Sell25,000$141.07$3,526,750.0041,265View SEC Filing Icon  
5/9/2018Sell25,000$134.73$3,368,250.0035,968View SEC Filing Icon  
4/4/2018Sell25,000$137.17$3,429,250.0035,968View SEC Filing Icon  
3/28/2018Sell25,000$137.33$3,433,250.0035,968View SEC Filing Icon  
See Full Table

Scott B. Ullem Buying and Selling Activity at Edwards Lifesciences

This chart shows Scott B Ullem's buying and selling at Edwards Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edwards Lifesciences Company Overview

Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $85.94
Low: $85.38
High: $87.20

50 Day Range

MA: $90.15
Low: $84.87
High: $95.56

2 Week Range

Now: $85.94
Low: $60.57
High: $96.12

Volume

3,895,701 shs

Average Volume

2,826,513 shs

Market Capitalization

$51.73 billion

P/E Ratio

37.37

Dividend Yield

N/A

Beta

1.05